Guidance for switching from off-label antipsychotics to pimavanserin for Parkinson’s disease psychosis: An expert consensus

Authors

Kevin J. Black, Washington University School of Medicine in St. Louis
Henry Nasrallah, Washington University School of Medicine in St. Louis
et al

Journal

CNS Spectrums

Publication Date

2018

Volume

23

Issue

6

Inclusive Pages

402-413

Document Type

Open Access Publication

DOI

10.1017/S1092852918001359

Rights and Permissions

Black, K., Nasrallah, H., Isaacson, S., Stacy, M., Pahwa, R., Adler, C., . . . Stahl, S. (2018). Guidance for switching from off-label antipsychotics to pimavanserin for Parkinson’s disease psychosis: An expert consensus. CNS Spectrums, 23(6), 402-413. doi:10.1017/S1092852918001359. © Cambridge University Press 2018. http://journals.cambridge.org

Recommended Citation

Black, Kevin J.; Nasrallah, Henry; and et al, "Guidance for switching from off-label antipsychotics to pimavanserin for Parkinson’s disease psychosis: An expert consensus." CNS Spectrums. 23, 6. 402-413. (2018).
https://digitalcommons.wustl.edu/open_access_pubs/7451